/

Research

Non-Hallucinogenic DMT? Psilera Bioscience Reports Progress on 'Well-Tolerated' Derivative

Non-Hallucinogenic DMT? Psilera Bioscience Reports Progress on ‘Well-Tolerated’ Derivative

,
Further in vivo studies with PSIL-002 will evaluate its antidepressant, anxiolytic, and anti-addictive properties, specifically targeting alcohol consumption.
You Can Make ‘Bad Trips’ Good with Storytelling, Psychedelics Study Shows

You Can Make ‘Bad Trips’ Good with Storytelling, Psychedelics Study Shows

Evidence supports the idea that the possibly unpleasant nature of the psychedelic experience is an integral part of its therapeutic benefits.
Microdosing Psilocybin and LSD Rises During Pandemic, Global Drug Survey FindsShutterstock.com

Microdosing LSD and Psilocybin Rises During Pandemic, Global Drug Survey Finds

,
The report also explores how microdosing may impact the use of other prescribed mental health medications.

Can Psychedelics Cure Chronic Pain? This Promising Study Lays Groundwork for Future Clinical Trials

Nine out of the 11 chronic pain sufferers interviewed say they experienced some kind of lasting pain reduction while self-medicating with psychedelics.
PharmaTher Believes Ketamine Could Treat This Rare Neurological ConditionShutterstock.com

PharmaTher Believes Ketamine Could Treat This Rare Neurological Condition

,
The company is also exploring if ketamine can treat other neurological conditions, including Parkinson’s Disease, ALS, and CRPS.

New Evidence Microdosing Psychedelics Reduces Anxiety and Depression

,
This study also showed microdosers were less likely to use alcohol and were most likely to abstain from consuming alcohol entirely.

How Dr. Monnica Williams Created Canada’s First Psychedelic Master’s Degree Program: ‘Nobody Took Me Seriously’

After two long years of preparing documents and presenting to various committees, the program is in its final stages, and the University of Ottawa will soon begin accepting applications for the fall semester.

Jada Pinkett Smith Tackles Exclusion of People of Color From Psychedelic Research on ‘Red Table Talk’

“We know nothing scientific about psychedelics and people of color and how appropriate our treatments are for people in those communities," says psychedelic researcher Dr. Monnica Wiliams.
Shutterstock.com

American Overdose Deaths Reach Record High During COVID Pandemic—And New Study Shows Psychedelics Can Help

“After adjusting for a range of potential confounders, psychedelic use remained independently associated with a significantly reduced odds of subsequent daily opioid use,” researchers say.

© 2023 Psychedelic Spotlight. | Owned and operated by PSYC Media Corporation, Inc. a US publicly traded company (OTCPink: PSYC) | All Rights Reserved.